Question from DITA Pharma SC: any good practice for topic-based review?

[josef.pellizzari@novartis.com]

Hi all,

In the last DITA Pharma SC a question
popped up around reviewing: is there any good practice or process for topic-based
review? As "reviewing" is associated with "enterprise"
the Pharma SC was looking at us or the Adoption SC for answers.

I remember vaguely that we discussed
reviewing as one potential business case for an aggregated document, but
as far as I remember we never spent any time on topic-based reviewing for
 business documents. Anything to carry back to the Pharma colleagues?

A second question was around relationships
of topics. In Pharma documents (and Pharma SC thinks also in business documents)
we often have the same information in different forms for different audiences
or different parts of the documumentation (summary vs. full detail, lay
language vs. expert language, etc). I cannot recall that we spent any time
on this, or that Rob's model would take this into account. Right?

Best regards,

Josef

Josef Pellizzari
Novartis Pharma AG
CHBS, WSJ-154.2.03C.12
Novartis Pharma AG
Forum 1
Novartis Campus
CH-4056 Basel
Switzerland
Phone: +41 61 3248825
Fax: +41 61 6961312
Email : josef.pellizzari@novartis.com